A Groupwide Phase II Study of Trastuzumab (Herceptin) in Metastatic Osteosarcoma Patients With Tumors That Overexpress HER2.
Phase of Trial: Phase II
Latest Information Update: 01 Feb 2013
At a glance
- Drugs Trastuzumab (Primary) ; Cisplatin; Doxorubicin; Etoposide; Filgrastim; Folinic acid; Folinic acid; Ifosfamide; Methotrexate
- Indications Osteosarcoma
- Focus Adverse reactions
- 31 Aug 2018 Biomarkers information updated
- 30 Jun 2009 New source identified and integrated (New Jersey Cancer Trial Connect).
- 30 Jun 2009 Additional lead investigators identified as reported by New Jersey Cancer Trial Connect.